Animal research

Peptides in canine & feline research

A surprising amount of the peptide literature people quote for humans was originally generated in animal models. Here's what the veterinary and pre-clinical research actually says — compound by compound, with citations.

Important: Peptide Logix products are laboratory research materials. Nothing on this page is veterinary advice, and none of these products are approved for administration to pets. Any animal health decision belongs with a licensed veterinarian.

BPC-157

Tendon, ligament and gut healing

The most-studied compound in animal models by a wide margin — nearly all of the foundational BPC-157 literature is rodent and canine tissue work. Reported effects include accelerated tendon-to-bone healing, transected Achilles and quadriceps repair, and protection of the gastrointestinal lining against NSAID damage.

Key literature

  • Krivic A. et al., "Modulation of early functional recovery of Achilles tendon to bone unit after transection by BPC 157," J Orthop Res, 2006.
  • Chang C.H. et al., "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration," J Appl Physiol, 2011.
  • Sikiric P. et al., "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract," Curr Pharm Des, 2011.

TB-500 (Thymosin Beta-4)

Soft tissue repair, wound closure

Thymosin beta-4 is naturally present in mammalian tissue and is one of the few peptides with a genuine equine/canine veterinary research history. Animal models report faster dermal wound closure, improved angiogenesis, and reduced fibrosis after cardiac and muscular injury.

Key literature

  • Malinda K.M. et al., "Thymosin β4 accelerates wound healing," J Invest Dermatol, 1999.
  • Bock-Marquette I. et al., "Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair," Nature, 2004.
  • Philp D. & Kleinman H.K., "Animal studies with thymosin β4, a multifunctional tissue repair and regeneration peptide," Ann N Y Acad Sci, 2010.

GHK-Cu

Skin, coat quality, wound remodeling

A copper-binding tripeptide originally isolated from human plasma and studied extensively in rodent and rabbit wound models. Literature reports increased collagen and glycosaminoglycan synthesis and improved hair-follicle activity — the reason it appears in veterinary dermatology discussion.

Key literature

  • Pickart L. & Margolina A., "Regenerative and protective actions of the GHK-Cu peptide," Int J Mol Sci, 2018.
  • Canapp S.O. et al., "The effect of topical tripeptide-copper complex on healing of ischemic open wounds," Vet Surg, 2003.

NAD+

Cellular energy in aging animals

NAD+ decline with age is documented across mammalian species. Rodent work shows restoring NAD+ improves mitochondrial function, muscle endurance and metabolic markers — which is why it appears in senior-pet longevity research discussion.

Key literature

  • Mills K.F. et al., "Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice," Cell Metab, 2016.
  • Gomes A.P. et al., "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging," Cell, 2013.

Thymosin Alpha-1

Immune modulation

Used in human immunology research and studied in feline models for immune-mediated conditions. Literature focuses on T-cell maturation and modulation of chronic inflammatory response.

Key literature

  • Garaci E. et al., "Thymosin α1: from bench to bedside," Ann N Y Acad Sci, 2007.
  • Romani L. et al., "Thymosin α1 activates dendritic cells for antifungal Th1 resistance," Blood, 2004.

Research-grade material, verified purity

99%+ purity, third-party USA lab tested, COA published per batch.